Themis Medicare Limited (BOM: 530199)

Market Cap	25.07B
Revenue (ttm)	4.20B
Net Income (ttm)	529.90M
Shares Out	92.04M
EPS (ttm)	5.75
PE Ratio	47.38
Forward PE	n/a
Dividend	0.50 (0.18%)
Ex-Dividend Date	Jul 12, 2024

Volume	9,418
Open	268.25
Previous Close	262.95
Day's Range	261.70 - 277.00
52-Week Range	152.65 - 304.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Themis Medicare

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Th...

• Industry: Drug Stores and Proprietary Stores
• Founded: 1952
• Employees: 1,509
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530199

Financial Performance

In 2023, Themis Medicare's revenue was 3.82 billion, an increase of 7.74% compared to the previous year's 3.54 billion. Earnings were 435.24 million, a decrease of -23.51%.